Gazzard BG - Search Results

1

The efficacy of lopinavir in individuals experiencing protease inhibitor failure.

Gilleece YC, Qazi NA, Morlese JF, Mandalia S, Gazzard BG, Pozniak AL, Nelson MR. Gilleece YC, et al. Among authors: gazzard bg. J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):238-40. doi: 10.1097/00126334-200302010-00018. J Acquir Immune Defic Syndr. 2003. PMID: 12571536 Clinical Trial. No abstract available.

2

Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance.

Walsh JC, Pozniak AL, Nelson MR, Mandalia S, Gazzard BG. Walsh JC, et al. Among authors: gazzard bg. J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):278-87. doi: 10.1097/00126334-200207010-00003. J Acquir Immune Defic Syndr. 2002. PMID: 12131564

3

Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin.

Gilleece YC, Browne RE, Asboe D, Atkins M, Mandalia S, Bower M, Gazzard BG, Nelson MR. Gilleece YC, et al. Among authors: gazzard bg. J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):41-6. doi: 10.1097/01.qai.0000174930.64145.a9. J Acquir Immune Defic Syndr. 2005. PMID: 16123680 Clinical Trial.

4

The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individuals.

Annan NT, Nelson M, Mandalia S, Bower M, Gazzard BG, Stebbing J. Annan NT, et al. Among authors: gazzard bg. J Acquir Immune Defic Syndr. 2009 Jun 1;51(2):140-6. doi: 10.1097/QAI.0b013e3181a56e81. J Acquir Immune Defic Syndr. 2009. PMID: 19352201

5

Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?

Morlese JF, Qazi NA, Gazzard BG, Nelson MR. Morlese JF, et al. Among authors: gazzard bg. AIDS. 2002 Sep 6;16(13):1840-1. doi: 10.1097/00002030-200209060-00023. AIDS. 2002. PMID: 12218402 No abstract available.

6

True gynaecomastia, another manifestation of immune reconstitution disease?

Qazi NA, Morlese JF, King DM, Ahmad RS, Gazzard BG, Nelson MR. Qazi NA, et al. Among authors: gazzard bg. Int J STD AIDS. 2002 Jan;13(1):59-65. doi: 10.1258/0956462021924514. Int J STD AIDS. 2002. PMID: 11802933 No abstract available.

7

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study.

Matthews GV, Sabin CA, Mandalia S, Lampe F, Phillips AN, Nelson MR, Bower M, Johnson MA, Gazzard BG. Matthews GV, et al. Among authors: gazzard bg. AIDS. 2002 Jan 4;16(1):53-61. doi: 10.1097/00002030-200201040-00008. AIDS. 2002. PMID: 11741163 Clinical Trial.

8

Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.

Walsh JC, Mandalia S, Gazzard BG. Walsh JC, et al. Among authors: gazzard bg. AIDS. 2002 Jan 25;16(2):269-77. doi: 10.1097/00002030-200201250-00017. AIDS. 2002. PMID: 11807312

9

Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen.

Boffito M, Kurowski M, Kruse G, Hill A, Benzie AA, Nelson MR, Moyle GJ, Gazzard BG, Pozniak AL. Boffito M, et al. Among authors: gazzard bg. AIDS. 2004 Jun 18;18(9):1291-7. doi: 10.1097/00002030-200406180-00007. AIDS. 2004. PMID: 15362661

10

Clinical characteristics of IRIS syndrome in patients with HIV and tuberculosis.

Michailidis C, Pozniak AL, Mandalia S, Basnayake S, Nelson MR, Gazzard BG. Michailidis C, et al. Among authors: gazzard bg. Antivir Ther. 2005;10(3):417-22. doi: 10.1177/135965350501000303. Antivir Ther. 2005. PMID: 15918332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters